drugset / Trial / NCT02701127

Molecular Effects of Vitamin B3 (Niacinamide) in Acute Kidney Injury

NCT02701127

Phase 0 Completed 55 enrolled Beth Israel Deaconess Medical Center
RandomizedParallel-groupDouble-blindOther

Summary

This is a single center, randomized, single-blind, placebo-controlled study to evaluate the safety and biochemical effects of niacinamide on metabolic parameters of the kidney in patients undergoing cardiac surgery.

Timeline

Start
2016-03
Primary completion
2017-02
Completion
2017-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nicotinamide Other / unclassified 1 g Oral
Comparator Nicotinamide Other / unclassified 3 g Oral

Indications